The Clinical Syndrome of Striatal Dopamine Deficiency
- 30 May 1985
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 312 (22) , 1418-1421
- https://doi.org/10.1056/nejm198505303122203
Abstract
Exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces a syndrome that resembles Parkinson's disease. To compare the biochemical abnormalities produced by this compound in human beings with those occurring in Parkinson's disease, we examined biogenic amine metabolites in cerebrospinal fluid and urine from six patients with MPTP-induced parkinsonism and eight patients with Parkinson's disease.This publication has 10 references indexed in Scilit:
- Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s DiseaseCanadian Journal of Neurological Sciences, 1984
- Urinary Catecholamine Metabolites Distinguish Different Types of Sympathetic Neuronal Dysfunction in Patients with Orthostatic HypotensionJournal of Clinical Endocrinology & Metabolism, 1983
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Relation Between Plasma and Cerebrospinal Fluid Levels of 3-Methoxy-4-HydroxyphenylglycolScience, 1983
- Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethlene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometryJournal of Mass Spectrometry, 1981
- Is the mesocortical dopaminergic system involved in Parkinson disease?Neurology, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Aging and Extrapyramidal FunctionArchives of Neurology, 1977
- ParkinsonismNeurology, 1967